retroviruses (HIV too) Flashcards

1
Q

how do retroviruses work?

A

use reverse transcription to convert RNA –> DNA, integrate into host genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the components of a retrovirus structure?

A

structural protines –> envelop, gag
viral enzymes –> reverse transcriptase, integrase, protease
viral genome –> 2 RNA molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

name some accessory proteins

A

-tat (tax)= transactivator req for viral gene transcription
-rev (rex)= nuclear exporter
-vif
vpr
vpu (release)
nef

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

whats the life cycle?

A

1) binding and entry
2) reverse transcription –> in cyto, ERROR prone
3) genome integration –> viral integrase
4) viral gene transcription –> tat transactivator
5) virus assembly and release –> vpu req for virus release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HERV- Human endogenous retrovirus

A
  • 8-10% of human genome
  • most defective and chill
  • may be assoc with cancers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

AIDS defining cancers

A
  • kaposis (HHV8)
  • non hodgkins lymphona (HHV8, EBV)
  • Cervical (HPV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are some challeneges with treating HIV positive cancers?

A
  • atypical path + higher grade tumors
  • poorer outcomes
  • higher rate of relapse
  • rapidly invasive
  • develops at younger age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are human diseases assoc with HTLV?

A
  • Adult T cell leuk/lymphoma (ATL)
  • HTLV1-assocaited-myelopathy (HAM)
  • Uveitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what disease does HAM resemble?

A

MS –> weakness, stiffness of legs

tropical spastic paraparesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

in what demographics do we see HTLV

A
japanese
caribbean
south america
africa
iran
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HTLV transmission. On that note, can you detect HTLV in the blood?

A
  • mother-child during breastfeeding
  • sex
  • infx blood/ needles

** requires direct cell to cell contract. Not seen in blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Markers for HIV dz in patient

A

CD4 count correlates to dz progression

Plasma HIV RNA level= virla load= measure of ongoing replicaiton in lymphoid tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

envelope protein markers of HIV? Which is involved in entry?

A

Gp40, GP120

GP120 binds TCR and CCR5 on t cell surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sup with the CCR5 d32 mutation

A

protective. 32 bp deletion causing translational frameshift/ truncation that prevents surface expression of CCR5. HIV can’t get into T cell.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical manifestations of HIV?

A

initial infection –> mono like, +- aseptic meningitis,

  • usu 2-3 weeks post HIV exposure
  • occurs in 50% of pt but USUALLY UNRECOGNIZED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

signs/sx of HIV infection (primary)

A
fever
fatigue
maculopapular rash
myalgia
HA
pharyngitis
cervical LAD
arthralgia
oral ulcers
weightloss
oral candida
17
Q

basics: opportunistic infection. how can you prevent?

A

infx that takes advantage of weakened immune sys

usu CD4 <200

try to prevent by restoring CD4 count with antiretrovirals

18
Q

name some opportunistic infx

A
PCP
kaposi sarcoma
thrush --> considered once it travels from mouth to esophagus
CMV retinitis
CNS toxoplasmosis
extrapulm TB
19
Q

Whats the goal of antiviral therapy? clincally and immunulogically

A
  • inhibit entry/replication
  • prevent deterioration of immune sys
  • prevent opp infx
  • reduce hospitalizations and long term care use
20
Q

HIV has been hard to treat because….

A

God! Just kidding, viral evolution.

seriously, viral reverse transcriptase is ERROR prone, creates plenty of viral variants that evolve from initial inoculum

one drug is never enough. 2-3 HAART always

21
Q

What are the targets of HAART?

A

Protease inhibitors
entry inhibitors
reverse transcriptase inhibitors (NRTI, NNRTI)

22
Q

protease inhibitors

A

-navir

inhibit HIV-1 protease POL GENE –> this cleaves HIV mRNA into functional products
-bonus –> boosts other concentrations because P450 inhibitor

23
Q

side effects of Protease inhibitors

A

hyperglycemia, GI intolerana, lipodystrophy

indinavir= neuropathy, hematuria
rifampin= potent CYP INDUCER
24
Q

integrase inhibitors

A

___“tegr”____ (get it, like inTEGRase)

inhibit HIV genome integration into host cell csome by REVERSIBLE INHIBITION OF HIV INTEGRASE

25
Q

major side effect of integrase inhibitors?

A

increased CK

26
Q

NRTIs

A

nucleoSide (except Tenofovir= nucleoTide) that lacks 3’OH –> competitively binds reverse transcriptase and terminates DNA chian

must have P activation

27
Q

side effects of NRTIs? Which is used in pregnancy?

A

Zidovudine in pregnancy
- causes bone marrow suppression –> neutropenia, anemia

lactic acidosis

stocking glove neuropatyh

28
Q

NNRTIs

A

DO NOT REQUIRE P ACTIVATION

bind to reverse transcriptase at diffferent site from NRTI

29
Q

side effects of NNRTIs. should you use these in pregnancy?

A

rash
hapatotoxicity
vivid dreams
CNS symptoms

delavirdine and efavirenz are contraincidcated in pregnancy

30
Q

entry/fusion inhibitors

A

maraviroc –> binds CCR5, blocks gp120

BMS-663068= –> fusion inhibitor

31
Q

how do we dx HIV in the lab?

A

ELISA followed by western

  • can be false neg in first 1-2 months
  • can be false positive in infants born to HIV mom due to placental crossing of anti-gp120
32
Q

what infections are seen with CD4< 500

A
candida
EBV
bartonella henselae
HHV8
cryptosporidium
HPV
33
Q

infections seen in CD4 < 200

A

PJP
Jc virus reactivation
HIV dementia

34
Q

infections seen in CD4 <100

A
aspergillus
histoplasma
candida albicans
cryptocococcus
CMV
mycobacterium avium
EBV
toxoplasma gondii